2019 | 2020 | 2021 | Absolute Change | Rel. Change | Absolute Change | Rel. Change | |
---|---|---|---|---|---|---|---|
2019–2020 | 2019–2020 | 2020–2021 | 2020–2021 | ||||
All hospitalizations, n | 16,051 | 14,178 | 13,273 | -1,873 | -11.7% | -905 | -6.4% |
Age, mean (± sd) | 73.81 (± 9.04) | 73.46 (± 9.14) | 73.41 (± 9.23) | -0.35 | -0.5% | -0.05 | -0.1% |
Men, n (%) | 13,663 (85.1%) | 12,039 (84.9%) | 11,150 (84.0%) | -1,624 (-0.2%) | -0.2% | -889 (-0.9%) | -1.1% |
In-hospital death, n (%) | 1,235 (7.7%) | 1,117 (7.9%) | 1,129 (8.5%) | -118 (+ 0.2%) | 2.4% | + 12 (+ 0.6%) | 8.0% |
In-hospital stay, d, median (IQR) | 7 (4–11) | 6 (4–11) | 6 (4–10) | -1 | -14.3% | 0 | 0.0% |
Comorbidities: | |||||||
Primary HT | 10,775 (67.1%) | 9,782 (69.0%) | 9,146 (68.9%) | -993 (+ 1.9%) | 2.8% | -636 (-0.1%) | -0.1% |
DLP | 6,553 (40.8%) | 5,858 (41.3%) | 5,711 (43.0%) | -695 (+ 0.5%) | 1.2% | -147 (+ 1.7%) | 4.1% |
DM-2 | 2,731 (17.0%) | 2,327 (16.4%) | 2,279 (17.2%) | -404 (-0.6%) | -3.5% | -48 (+ 0.8%) | 4.6% |
CKD | 3,861 (24.1%) | 3,158 (22.3%) | 2,946 (22.2%) | -703 (-1.8%) | -7.4% | -212 (-0.1%) | -0.4% |
CHD | 5,060 (31.5%) | 4,302 (30.3%) | 4,100 (30.9%) | -758 (-1.2%) | -3.7% | -202 (+ 0.5%) | 1.8% |
SARS-CoV2-infection | 0 (0.0%) | 49 (0.3%) | 64 (0.5%) | + 49 (+ 0.3%) | n/a | + 15 (+ 0.1%) | 39.5% |
Ruptured aortic abdominal aneurysm | |||||||
Hospitalizations, n | 2,164 (13.5%) | 2,080 (14.7%) | 1,995 (15.0%) | -84 (+ 1.2%) | 8.8% | -85 (+ 0.4%) | 2.5% |
Age, mean (± sd) | 76.10 (± 10.11) | 75.53 (± 10.36) | 75.29 (± 10.43) | -0.58 | -0.8% | -0.24 | -0.3% |
Men, n (%) | 1,743 (80.5%) | 1,639 (78.8%) | 1,585 (79.4%) | -104 (-1.7%) | -2.2% | -54 (+ 0.7%) | 0.8% |
Treatment: | |||||||
OR, n (%) | 788 (36.4%) | 728 (35.0%) | 695 (34.8%) | -60 (-1.4%) | -3.9% | -33 (-0.2%) | -0.5% |
EVAR, n (%) | 455 (21.0%) | 440 (21.2%) | 461 (23.1%) | -15 (+ 0.1%) | 0.6% | + 21 (+ 2.0%) | 9.2% |
combined, n (%) | 90 (4.2%) | 92 (4.4%) | 89 (4.5%) | + 2 (+ 0.3%) | 6.4% | -3 (0.0%) | 0.9% |
no intervention, n (%) | 831 (38.4%) | 820 (39.4%) | 750 (37.6%) | -11 (+ 1.0%) | 2.7% | -70 (-1.8%) | -4.6% |
In-hospital death, n (%) | 927 (42.8%) | 854 (41.1%) | 870 (43.6%) | -73 (-1.8%) | -4.2% | + 16 (+ 2.6%) | 6.2% |
In-hospital stay, d, median (IQR) | 6 (1–16) | 6.5 (1–17) | 6 (1–16) | 0.5 | 8.3% | -0.5 | -7.7% |
Non-ruptured abdominal aortic aneurysm | |||||||
Hospitalizations, n | 13,887 (86.5%) | 12,098 (85.3%) | 11,278 (85.0%) | -1,789 (-1.2%) | -1.4% | -820 (-0.4%) | -0.4% |
Age, mean (± sd) | 73.45 (± 8.81) | 73.11 (± 8.87) | 73.08 (± 8.96) | -0.34 | -0.5% | -0.03 | 0.0% |
Men, n (%) | 11,920 (85.8%) | 10,400 (86.0%) | 9,565 (84.8%) | -1,520 (+ 0.1%) | 0.2% | -835 (-1.2%) | -1.3% |
Treatment: | |||||||
OR, n (%) | 2,176 (15.7%) | 1,984 (16.4%) | 1,816 (16.1%) | -192 (+ 0.7%) | 4.7% | -168 (-0.3%) | -1.8% |
EVAR, n (%) | 6,970 (50.2%) | 6,159 (50.9%) | 5,660 (50.2%) | -811 (+ 0.7%) | 1.4% | -499 (-0.7%) | -1.4% |
combined, n (%) | 678 (4.9%) | 658 (5.4%) | 636 (5.6%) | -29 (+ 0.5%) | 9.9% | -22 (+ 0.2%) | 3.7% |
no intervention, n (%) | 4,054 (29.2%) | 3,297 (27.3%) | 3,166 (28.1%) | -757 (-1.9%) | -6.6% | -131 (+ 0.8%) | 3.0% |
In-hospital death, n (%) | 308 (2.2%) | 263 (2.2%) | 259 (2.3%) | -45 (-0.04%) | -2.0% | -4 (+ 0.1%) | 5.6% |
In-hospital stay, d, median (IQR) | 7 (4–10) | 6 (4–10) | 6 (4–10) | -1 | -14.3% | 0 | 0.0% |